Indian American biotech founder Suma Krishnan named to Forbes 50 Over 50 list

The gene therapy pioneer joins five other Indian-origin women honored across innovation, impact, and investment.

Suma Krishnan. / Forbes

Suma Krishnan, an Indian American drug developer and cofounder of Krystal Biotech, has been named to Forbes’ ‘50 Over 50’ list, which celebrates 200 women making significant contributions across business, science, and culture after the age of 50.

Krishnan, now 60, co-launched Krystal Biotech in Pittsburgh at the age of 51 to develop a novel gene therapy for dystrophic epidermolysis bullosa, a rare and painful skin disease. The treatment, Vyjuvek, became the first FDA-approved topical gene therapy for the condition in 2023. “I had to work with the regulators because they had never seen this,” Krishnan told Forbes. “It was completely new.”

This post is for paying subscribers only

SUBSCRIBE NOW

Comments

This is a Premium Article, available exclusively to our subscribers.

Read 500+ such News or articles every month by subscribing today!
Monthly

Free

Limited Access

Limited View

Free weekly E-Paper

Subscribe Now
Monthly

$10

Full Access

Unlimited View

Free weekly E-Paper

Free daily newsletter

Subscribe Now
Annual

$50

Full Access

Unlimited View

Free weekly E-Paper

Free daily newsletter

Subscribe Now
Start the conversation

Become a member of New India Abroad to start commenting.

Sign Up Now

Already have an account? Login